ESC Premium Access

CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial

Congress Presentation

About the speaker

Doctor Jonathan Sen

Baker Heart and Diabetes Institute, Melbourne (Australia)
0 follower

6 more presentations in this session

Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)

Speaker: Professor G. Boriani (Modena, IT)


Atrial fibrillation risk factor burden and disease onset across age decades.

Speaker: Associate Professor B. Morseth (Tromso, NO)


Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis.

Speaker: Assistant Professor D. Pastori (Rome, IT)


Long term antithrombotic treatment in atrial fibrillation patients undergoing coronary surgery.

Speaker: Doctor M. Skibniewski (Linkoping, SE)


Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Speaker: Associate Professor B. Rocca (Rome, IT)


Access the full session

Atrial Fibrillation, Platelet Aggregation and Outcomes

Speakers: Doctor J. Sen, Professor G. Boriani, Associate Professor B. Morseth, Assistant Professor D. Pastori, Doctor M. Skibniewski...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb